Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Apr-Jun;34(2):73-77.
doi: 10.4103/0970-9371.203567.

Evaluation of cytology in lung cancer diagnosis based on EBUS-TBNA

Affiliations

Evaluation of cytology in lung cancer diagnosis based on EBUS-TBNA

Zhengwei Dong et al. J Cytol. 2017 Apr-Jun.

Abstract

Aims: Endobronchial ultrasound (EBUS) is a relatively new modality that can be used to guide transbronchial needle aspiration (TBNA) of mediastinal lymph nodes. At present, researches on the sensitivity and specificity of cytopathology based on the EBUS-TBNA are deficient; therefore, we want to evaluate the value of cytology based on the EBUS-TBNA in this article.

Materials and methods: We reviewed the 379 cases that underwent the EBUS-TBNA in Shanghai Pulmonary Hospital from April 2010 to May 2011. Discarding the 139 cases with insufficient cells, we analyzed the remaining 240 cases that had enough cells on the smears.

Statistical analysis used: The Statistical Package for the Social Sciences version 15.0 (SPSS Inc., Chicago, IL) was used for data analysis. A P value of <0.05 was considered significant.

Results: We found that the cytologic diagnosis of sensitivity and specificity reached 94.52% and 95.12%, respectively. The sensitivity of squamous cell carcinoma, adenocarcinoma, and small cell carcinoma was up to 88.24%, 100.00%, and 96.00%, respectively. The specificity of squamous cell carcinoma, adenocarcinoma, and small cell carcinoma reached to 100.00%, 100.00%, and 99.25%, respectively.

Conclusion: Here, we report that the cytological examination of EBUS-TBNA should be acknowledged as a simple, fast, and safe procedure that provides a reasonable sensitivity and specificity of diagnosis in lung cancer.

Keywords: Cell block; EBUS-TBNA; cytopathology; differential diagnosis; lung cancer.

PubMed Disclaimer

Conflict of interest statement

There are no conflicts of interest.

Figures

Figure 1
Figure 1
Immunocytochemistry of CEA, TTF-1, p63, and SYN. (a) The immunostain of CEA in adenocarcinoma. It showed membrane positive (IHC: CEA ×400). (b) The immunostain of TTF-1 in adenocarcinoma. It showed nuclei positive (IHC: TTF-1 ×400). (c) A case of squamous cell carcinoma, expressed with p63. The nuclei was stained positive (p63 ×400). (d) The immunostain of SYN in small cell carcinoma (IHC : SYN ×400)

Similar articles

Cited by

References

    1. Awasthi A, Gupta N, Srinivasan R, Nijhawan R, Rajwanshi A. Cytopathological spectrum of unusual malignant pleural effusions at a tertiary care centre in north India. Cytopathology. 2007;18:28–32. - PubMed
    1. Hasteh F, Lin GY, Weidner N, Michael CW. The use of immunohistochemistry to distinguish reactive mesothelial cells from malignant mesothelioma in cytologic effusions. Cancer Cytopathol. 2010;118:90–6. - PubMed
    1. Herth F, Becker HD, Ernst A. Conventional vs Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration. Chest. 2004;125:322–5. - PubMed
    1. Skov BG, Baandrup U, Jakobsen GK, Kiss K, Krasnik M, Rossen K, et al. Cytopathologic diagnoses of fine-needle aspirations from endoscopic ultrasound of the mediastinum. Cancer Cytopathol. 2007;111:234–41. - PubMed
    1. Sakairi Y, Nakajima T, Iizasa T, Itami M, Yoshino I, Kimura H. Diagnosis of lymph node metastasis by endobronchial ultrasound-guided transbronchial needle aspiration more than 1 year after lung cancer resection: Report of a case. Surg Today. 2011;41:983–5. - PubMed